2025Q4
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Access Industries Holdings LLC | — | 13,432,919 | Jan 2, 2020 |
| Access Industries Management, Llc | — | 13,432,919 | Jan 2, 2020 |
| Blavatnik Len | — | 13,432,919 | Jan 2, 2020 |
| Access Industries, Llc | — | 13,432,919 | Jan 2, 2020 |
| Clal Biotechnology Industries Ltd. | — | 13,432,919 | Jan 2, 2020 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jun 14, 2023 | Jul 5, 2023 | Darvish Nissim | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 16, 2023 | Jun 20, 2023 | Quigley Jill M. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 14, 2023 | Jun 16, 2023 | Fatal Sigal | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 5, 2023 | Fatal Sigal | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 16, 2023 | Mar 23, 2023 | Moses Alan Charles | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 16, 2023 | Mar 23, 2023 | Nicaise Claude | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 16, 2023 | Mar 23, 2023 | Cohen Neil Harris | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 16, 2023 | Mar 23, 2023 | Darvish Nissim | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 3, 2023 | Jan 5, 2023 | OrbiMed Israel GP Ltd. | 10% Owner | Sell | 17.5 | -336,900 | -13.07% | ✗ | $1.2M |
| Jan 3, 2023 | Jan 5, 2023 | Mor George Adi | Chief Scientific Officer | Sell | 41.3 | -13,800 | -2.37% | ✓ | $69.4K |
| Nov 16, 2022 | Nov 18, 2022 | Cohen Neil Harris | Director | Sell | 27.5 | -2,409 | -19.41% | ✗ | $4.8K |
| Nov 16, 2022 | Nov 17, 2022 | Mor George Adi | Chief Scientific Officer | Sell | 17.5 | -582,023 | -50.00% | ✗ | $1.2M |
| Nov 15, 2022 | Frankel Matthew Bejosa | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 21, 2022 | Quigley Jill M. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 16, 2022 | Jun 21, 2022 | Marvin Donald | CFO | Buy | 90.0 | +500 | 33.33% | ✗ | $1.6K |
| May 24, 2022 | May 25, 2022 | Maryles Joel Michael | Director | Buy | 90.0 | +433 | 43.30% | ✗ | $1.2K |
| May 18, 2022 | May 19, 2022 | Cohen Neil Harris | Director | Buy | 90.0 | +2,000 | 19.21% | ✗ | $6.4K |
| Mar 18, 2022 | Mar 21, 2022 | Maryles Joel Michael | Director | Buy | 90.0 | +1,000 | 100.00% | ✗ | $4.3K |
| Mar 14, 2022 | Mar 21, 2022 | Marvin Donald | CFO | Buy | 90.0 | +1,250 | 38.46% | ✗ | $5K |
| Mar 14, 2022 | Mar 15, 2022 | Pfost Dale R | CEO | Buy | 90.0 | +2,500 | 100.00% | ✗ | $9.9K |
| Mar 14, 2022 | Mar 15, 2022 | Cohen Neil Harris | Director | Buy | 91.3 | +6,000 | 136.09% | ✗ | $26.1K |
| Mar 11, 2022 | Mar 14, 2022 | Darvish Nissim | Director | Buy | 90.0 | +1,200 | 100.00% | ✗ | $5.1K |
| Mar 7, 2022 | Mar 9, 2022 | Darvish Nissim | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 7, 2022 | Mar 9, 2022 | Nicaise Claude | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 7, 2022 | Mar 9, 2022 | Cohen Neil Harris | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 7, 2022 | Mar 9, 2022 | Moses Alan Charles | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 7, 2022 | Mar 9, 2022 | Maryles Joel Michael | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 6, 2021 | Dec 8, 2021 | Cohen Neil Harris | Director | Buy | 91.3 | +2,000 | 83.02% | ✗ | $14.9K |
| Nov 12, 2021 | Marvin Donald | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 4, 2021 | Pfost Dale R | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| May 7, 2021 | May 10, 2021 | Fatal Sigal | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 19, 2021 | Apr 21, 2021 | SQUINTO STEPHEN P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 19, 2021 | Apr 21, 2021 | Nicaise Claude | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 19, 2021 | Apr 21, 2021 | Moses Alan Charles | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 19, 2021 | Apr 21, 2021 | Maryles Joel Michael | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 19, 2021 | Apr 21, 2021 | Darvish Nissim | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 19, 2021 | Apr 21, 2021 | Cohen Neil Harris | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 26, 2021 | OrbiMed Israel GP Ltd. | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 16, 2021 | Mar 26, 2021 | Cohen Neil Harris | Director | Buy | 95.0 | +2,409 | 100.00% | ✗ | $100K |
| Mar 25, 2021 | Nicaise Claude | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 25, 2021 | Moses Alan Charles | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 25, 2021 | Darvish Nissim | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 25, 2021 | SQUINTO STEPHEN P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 25, 2021 | Fatal Sigal | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 25, 2021 | Maryles Joel Michael | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 25, 2021 | Aharon Arnon | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 25, 2021 | Mor George Adi | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 16, 2021 | Mar 18, 2021 | OrbiMed Israel GP Ltd. | 10% Owner | Neutral | 90.0 | +288,170 | 12.58% | ✗ | - |
| Mar 16, 2021 | Mar 18, 2021 | THIEL PETER | 10% Owner | Neutral | 90.0 | +230,536 | 26.26% | ✗ | - |
| Mar 18, 2021 | THIEL PETER | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 16, 2020 | Mar 12, 2021 | Polovets Stanislav | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 12, 2021 | Polovets Stanislav | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 11, 2021 | Fine Andrew | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 16, 2020 | Mar 11, 2021 | Cohen Neil Harris | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 11, 2021 | Cohen Neil Harris | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| May 7, 2020 | DiPalma Stephen J. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 2, 2020 | Gonen Ofer | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 2, 2020 | Access Industries Holdings LLC | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 2, 2020 | HARDY REGINALD L | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 2, 2020 | Alon Ruth | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 2, 2020 | Burgin Jonathan | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 2, 2020 | VERU DENNISON T | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 2, 2020 | Haluska Frank | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 2, 2020 | Gilon Ohev-Zion Michal | VP, Research and Development | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 2, 2020 | Roshan Salar | Head of Business Development | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 2, 2020 | Daly Sean T | VP, Clinical Operations | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 2, 2020 | Knickerbocker Ron | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 2, 2020 | Kohlberg Isaac T. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 2, 2020 | Makov Efrat | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 2, 2020 | Kerstein David | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 2, 2020 | HOWARD LAWRENCE | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 31, 2019 | Gabriel Capital Management Ltd. | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |